Loranthus

Loranthus: A Comprehensive Reference

1. Identity and Botanical Classification

Genus and family. Loranthus is a genus of parasitic plants within the family Loranthaceae (the showy mistletoe family), which is placed in the order Santalales. Loranthus is a genus of parasitic plants that grow on the branches of woody trees and belongs to the family Loranthaceae, the showy mistletoe family. Loranthaceae comprises 73 genera and approximately 900 species, mostly aerial hemiparasitic plants. Loranthaceae is the largest family in the sandalwood order Santalales, including 76 genera and over 1,000 species, and is mainly distributed in tropical and subtropical regions of the Americas, Africa, Asia, and Australia, with a few species extending into temperate zones in Europe and East Asia.

Taxonomic history and species scope. The taxonomic history of the generic name Loranthus is complicated. In 1753, Carl Linnaeus used the name Loranthus for a genus of one species, Loranthus americanus, which was thus the type species. He later added other species, including Loranthus scurrula in 1762 and Loranthus europaeus in 1763. The number of species recognized in the genus has varied widely; at one time it included almost all mistletoes, but it was then split into many genera, leaving only L. europaeus from Europe eastwards and L. odoratus from tropical Asia. The Flora of China lists six species native to China (three endemic), stating that there are about ten species in total. In contemporary usage in medicinal and dietary supplement contexts, the term "Loranthus" is applied most frequently—but not exclusively—to several specific species with well-documented medicinal histories, including Loranthus parasiticus Merr., Loranthus micranthus Linn., Loranthus europaeus Jacq., Loranthus acaciae Zucc., Loranthus regularis, and Loranthus tanakae.

Key species with medicinal relevance.

• Loranthus parasiticus Merr. — L. parasiticus is a member of the Loranthaceae family and is an important medicinal plant with a long history of Chinese traditional use, known as Sang Ji Sheng (Chinese), benalu teh (Malay), and baso-kisei (Japanese), and is mostly distributed in the southern and southwestern regions of China. L. parasiticus is also known as Cichlanthus scurrula (L.) Tiegh., Loranthus chinensis var. formosanus Lecomte, Scurrula parasitica L., Loranthus scurrula L., and Taxillus parasiticus (L.) S.T.
• Loranthus micranthus Linn. — L. micranthus is a medicinal plant from the Loranthaceae family commonly known as an eastern Nigeria species of the African mistletoe, and is widely used in folkloric medicine to cure various ailments and diseases. It is a semiparasitic plant that grows on various host trees and shrubs, absorbing mineral nutrition and water from the host.
• Loranthus europaeus Jacq. — L. europaeus is a dioecious hemiparasitic plant widely distributed across southern and central Europe, with a strong preference for oak species, but it can also parasitize other broadleaf species such as Castanea sativa, Carpinus betulus, Betula pendula, and Acer spp. Magic and curative properties were attributed to Loranthus europaeus, the "true" golden bush, prevalently diffused in the Mediterranean territories of the Continent.
• Loranthus acaciae Zucc. — A species found in Saudi Arabia and other parts of the Middle East, studied for anti-diabetic and anti-inflammatory properties.
• Loranthus regularis — A traditional medicinal plant used widely throughout Asian countries such as Yemen and Saudi Arabia, and some African countries such as Ethiopia; belonging to family Loranthaceae, it can grow on several trees such as Zizyphus spina-christi, Ficus, and Acacia spp., and is considered a hemiparasitic shrub, taking its water and mineral requirements from these trees while photosynthesizing carbohydrates in its green leaves.
• Loranthus tanakae — A hemiparasitic plant native to East Asian countries including China, Japan, and Korea, with a long history in traditional medicine; historically used to treat many conditions including tumors, inflammatory joint diseases, and various respiratory disorders.

Hemiparasitic biology. Mistletoes are semiparasitic plants because they normally grow on various host trees and shrubs and depend on their respective host for mineral nutrition and water, although they produce their own carbohydrates through photosynthesis. Their haustoria form direct xylem connections with host trees, enabling the uptake of water and minerals. A critical consequence of this biology is that phytochemical composition is not fixed. L. micranthus, for example, demonstrates strong host and harvesting period dependency in both phytochemicals and biological activities.

Common preparations and dosage forms. Loranthus species are prepared for medicinal use in several forms across traditions: dried whole plant material (stems, leaves, and twigs); water decoctions boiled from the whole aerial parts; standardized hydroalcoholic (methanol or ethanol) extracts; aqueous extracts; and various solvent-specific fractions (n-butanol, chloroform, ethyl acetate) used in research settings. L. parasiticus (1 kg) was boiled in distilled water (10 liters) for approximately 3 hours at 115°C to produce a water extract, which was filtered, lyophilized, and the dried pellet stored at −20°C until use in one research preparation protocol. Moreover, L. parasiticus is one of the few Chinese medicinal herbs formulated into healthy herbal drinks in food processing pilot plants.

2. Traditional and Historical Use

Traditional Chinese Medicine (TCM)

Loranthus parasiticus is an important medicinal plant with a long history of Chinese traditional use. In TCM, it is catalogued under the category of herbs that expel Wind-Damp. Sāng Jì Shēng (桑寄生), known in English as Mulberry Mistletoe / Loranthus, belongs to the category of herbs that expel Wind-Damp in the Chinese Materia Medica and is one of the important herbs in traditional Chinese medicine (TCM), used as a component of classical herbal formulas and in tailored prescriptions. Classical texts indicate that its principal actions in TCM include tonifying the Liver and Kidney, expelling Wind-Damp, and calming a restless fetus. It was used for soreness, pain, weakness, numbness, and atrophy in the back, knees, and other joints, as well as for diuretic effects and treatment of hypertension. Mistletoe was described as "an all-purpose herb" due to its rich traditional uses and has been widely used in ethnomedicine for various purposes, including antihypertensive, anticancer, antispasmodic, and antidiabetic applications, as well as for treatment of epilepsy, headache, infertility, menopausal syndrome, and rheumatism. L. parasiticus, as a traditional herb of China, Japan, Indonesia, Malaysia, and Taiwan, has been tested and shown to exhibit a range of biological activities including antioxidant, neuroprotective, antinephrotoxic, antiviral, and antihepatotoxic activities.

Traditional Nigerian and African Ethnomedicine

Loranthus micranthus, also called African mistletoe, is a major Nigerian Loranthaceae plant used traditionally to treat hypertension. More broadly, Loranthus micranthus Linn. is a medicinal plant from the Loranthaceae family commonly known as an eastern Nigeria species of the African mistletoe and is widely used in folkloric medicine to cure various ailments and diseases. Traditional uses extend to treating diabetes, infectious diseases, diarrhea, and immune dysfunction. Loranthus ferrugineus from Loranthaceae is a mistletoe used medicinally for a variety of human ailments, with traditional decoctions of this parasitic shrub mainly used to treat high blood pressure and gastrointestinal complaints, with usage supported by experimental pharmacological investigations.

Middle Eastern and Arabian Traditional Medicine

The Loranthus genus has been demonstrated to be used in the treatment of a wide range of diseases including diabetes, inflammations, and cancers in Middle Eastern folk traditions. Loranthus acaciae Zucc. is employed in Saudi Arabia and neighboring regions, and Loranthus regularis has a documented history of use in Yemen, Saudi Arabia, and Ethiopia.

European Folk Medicine

Loranthus europaeus is a well-known and important medicinal plant with a long history of traditional medicine use. Loranthus europaeus is commonly known as European mistletoe and has been used in herbal medicine for centuries, with its most diversified pharmacological possessions comprising anti-inflammatory, antioxidant, and anticancer activities. Therapeutic plant applications include wound healing, gastrointestinal complaints, antiviral use, and anticancer therapy.

East Asian and South/Southeast Asian Use

Loranthus tanakae, a hemiparasitic plant native to East Asian countries including China, Japan, and Korea, has attracted considerable interest in ethnopharmacological studies because of its long history in traditional medicine, where it has been used to treat tumors, inflammatory joint diseases, and various respiratory disorders. In South and Southeast Asia, species parasitic on tea, mango, neem, and guava trees have been employed in traditional Ayurvedic and Malay herbal systems.

3. Key Constituents and Active Compounds

The phytochemical composition of Loranthus species varies significantly by species, host plant, geographic location, and harvesting season. The following classes of compounds have been consistently identified across the genus in peer-reviewed phytochemical analyses.

Flavonoids and Phenolic Compounds

Loranthus europaeus contains a wide range of bioactive compounds, including flavonoids (quercetin, rutin, epicatechin), phenolic acids, alkaloids, terpenes, and essential oils. Screening of individual phenolic compounds in methanolic extracts of L. europaeus revealed 22 identified compounds; five compounds — (+)-catechin, (−)-epicatechin, chlorogenic acid, hyperoside, and pinoresinol — were predominant. Phytochemical analysis of L. acaciae led to the isolation and characterization of four compounds: quercetin 3-O-β-D-glucopyranoside, quercetin 3-O-β-(6-O-galloyl)-glucopyranoside, (−)-catechin, and catechin 7-O-gallate; among these, the first two and catechin 7-O-gallate are isolated for the first time from this plant.

Sesquiterpene Lactones (Coriaria Lactones)

The key bioactive constituents in L. parasiticus include coriaria lactone, comprised of sesquiterpene lactones: coriamyrtin, tutin, corianin, and coriatin. In addition, two proanthocyanidins — AC trimer and (+)-catechin — have been recently discovered as novel to L. parasiticus.

Lignans

L. parasiticus has been shown to contain biologically active lignans. In one study, oral administration of 100 mg/kg of lignans isolated from L. parasiticus was as effective as oral administration of 0.3 mg/kg methotrexate (MTX) in reducing joint swelling, synovial hyperplasia, pannus formation, and levels of some systemic and local proinflammatory factors (serum IL-6 and IL-1β, joint synovium IL-17) in an animal model.

Alkaloids and Terpenoids

Loranthus micranthus also contains tannins, terpenoids, flavonoids, and alkaloids, which have been implicated in various pharmacological activities of the plant including antibacterial and antidiabetic properties. Phytochemical studies on L. micranthus leaves harvested from six different host trees revealed that alkaloids are preponderant in the extracts of certain host combinations. A study on petroleum ether extract of L. micranthus leaves parasitic on Persea americana harvested at different seasons showed only presence of alkaloids in April and July, proving harvesting period dependency in phytochemicals.

Saponins, Tannins, Glycosides

Qualitative phytochemical screening of L. micranthus revealed the presence of flavonoids, glycosides, saponins, phenolic compounds, phlobatannins, tannins, and terpenoids.

Proteins

Several studies showed that L. europaeus contains many bioactive compounds with a wide range of pharmacological effects, including proteinaceous constituents extracted from the yellow fruits that have demonstrated bactericidal activity.

Host-Dependency Effect on Composition

Because L. micranthus is a semiparasitic plant that grows on various host trees and shrubs, absorbing mineral nutrition and water from the host, the phytochemicals and biological activities of L. micranthus demonstrate strong host and harvesting period dependency. This is an important limitation for standardization of Loranthus-based preparations.

4. Mechanisms of Action

Multiple mechanisms have been proposed based on in vitro and animal studies, with the following being best supported by published research:

Antioxidant Activity

Methanol extracts of L. parasiticus with high total phenolic content were confirmed to possess strong antioxidant activity, suggesting that extracts of L. parasiticus may represent a natural source of antioxidants with neuroprotective, anticancer, and immunomodulatory effects. For L. acaciae, the chloroform fraction exhibited a high antioxidative and DPPH-radical inhibitory activity (85.4 and 88.3%, respectively).

Anti-inflammatory Pathways

Network pharmacology analysis of L. micranthus revealed 207 targets and 30 bioactive phytoconstituents; these compounds, including triterpenoids, alkaloids, steroids, and flavonoids, are known to have anti-inflammatory, antioxidant, antitumor, and immunomodulatory properties. Anti-inflammatory activity in specific species has been linked to inhibition of COX-2 and 5-lipoxygenase. For L. parasiticus, an aqueous extract (LPE) inhibited phosphorylation of Syk, PLCγ1/2, PKCδ, ERK, JNK, p38, and Akt; in the late phase, LPE decreased 5-lipoxygenase phosphorylation and COX-2 expression; the mechanisms of antiallergic properties include various targets such as Syk, Akt, ERK, JNK, p38, PLCγ1/2, PKCδ, 5-LO, and COX-2.

Vasorelaxation and Antihypertensive Mechanism

The study demonstrates that Loranthus micranthus reduces blood pressure through vasorelaxation and increased nitric oxide levels, with terpenoids and steroids identified as potential bioactive compounds. The n-butanol fraction (NBF-LMME) elicited the highest dose-dependent inhibitory effect on rat aorta pre-contracted with norepinephrine and KCl, followed in decreasing order by the water fraction, chloroform fraction, and ethyl acetate fraction.

Neuroprotective Mechanisms

The isolated compounds AC trimer and (+)-catechin from the aqueous fraction of L. parasiticus leaves showed potent neuroprotective activity in NG108-15 hybridoma cells with 93.38% and 102.41% cell viability at 1 mM, respectively; (+)-catechin exerted the strongest neuroprotective activity through reversal of effects on intracellular ROS generation, externalization of phosphatidylserine, mitochondrial membrane potential dissipation, and sub-G1 cell population.

Antidiabetic Mechanisms

Multiple Loranthus species have been examined for antidiabetic effects in animal models. Other species from the family Loranthaceae showed antidiabetic, anti-inflammatory, and antioxidant activities; a recent study reported that Loranthus acaciae Zucc. might reduce blood glucose levels and downregulate markers of proinflammation and oxidative stress. In addition, Loranthus micranthus showed marked antidiabetic properties attributed to restoring redox status, and enhanced diabetic-induced damages in liver and kidney tissues and repaired glycolytic flux in STZ diabetic rats.

5. Scientific Evidence by Area of Use

5.1 Antidiabetic / Hypoglycemic Activity

Evidence level: Preliminary — animal models only; no human clinical trials identified.

The hypoglycemic and anti-hyperglycemic activities of dried leaves of Loranthus micranthus (Linn.) parasitic on Persea americana, Baphia nitida, Kola acuminata, Pentaclethra macrophylla, and Azadirachta indica were evaluated in normoglycemic and alloxan-induced diabetic albino rats. Normoglycemic and alloxan-induced diabetic rats were treated intraperitoneally with 200 mg/kg of respective methanolic extracts of Loranthus micranthus, with glibenclamide as a positive control and 20% Tween 20 solution as a negative control. The studies indicate that the crude methanolic extract of Loranthus micranthus exhibited statistically significant hypoglycemic (P < 0.001) and anti-hyperglycemic (P < 0.001) activities in normoglycemic and alloxan-induced diabetic albino rats, respectively.

For L. acaciae, a PMC-published study investigated antidiabetic activity using alloxan-induced diabetic rats and a glucose tolerance test. The crude extract and chloroform fraction had the greatest hypoglycemic and antidiabetic effects; at a dose of 500 mg/kg, the chloroform fraction and crude extract produced a significant hypoglycemic effect in diabetic rats with 47.0% and 33.6% reduction in blood sugar levels, and 35.6% and 35.4% reductions in normoglycemic rats, respectively.

For L. regularis, a rat model study using streptozotocin (STZ) induction showed that treatment of diabetic rats with L. regularis extract markedly reduced elevated serum levels of glucose, ALT, AST, TC, TG, LDL, TNF-α, IL-1β, IL-6, caspase-3, NO, and PGE-2; L. regularis extract also improved serum levels of insulin and HDL. The elevated TBARS, TNF-α, IL-1β, and IL-6 levels in hepatic tissue of diabetic animals were reduced by L. regularis, and the extract significantly restored diminished hepatic GSH levels and enzymatic activities of SOD, CAT, GPx, GR, and GST in diabetic animals. All evidence in this area is from animal models; no randomized controlled human trials have been published.

5.2 Antihypertensive / Cardiovascular Activity

Evidence level: Preliminary — animal/ex vivo models only; no human clinical trials identified.

Loranthus micranthus is a major Nigerian Loranthaceae plant used traditionally to treat hypertension; the methanolic leaf extract has been shown to elicit anti-hypertensive activity in rats, but the mechanism remained unclear. A study was undertaken to study the effect of LM on pressor-induced contraction of rat aorta smooth muscles and serum lipid profiles in mice. The extract was partitioned to produce n-butanol, chloroform, ethyl acetate, and water fractions; median effective concentrations and maximum relaxation were determined against epinephrine and KCl pre-contracted rat aorta ring model; serum lipid profiles and nitric oxide (NO) were determined spectrophotometrically in mice administered orally 250 mg/kg body weight of each fraction for 21 days. The n-butanol fraction exhibited a maximum relaxation effect of 75.2% and an EC50 of 0.65 mg/mL against norepinephrine-induced contraction in rat aorta; NBF-LMME treatment significantly lowered total cholesterol and triglyceride levels by approximately 6% and 9.5%, respectively, compared to controls after 21 days. No human clinical data exist for this application.

5.3 Neuroprotective Activity

Evidence level: Preliminary — in vitro cell models only.

Loranthus parasiticus has been used as a compound for traditional medicine in Northeast Asia for a long time and is known to possess neuroprotective action; the effect of Loranthus parasiticus on allergic responses had remained unknown prior to targeted investigation. Isolated compounds AC trimer and (+)-catechin from the aqueous fraction of L. parasiticus leaves showed potent neuroprotective activity in NG108-15 hybridoma cells with 93.38% and 102.41% cell viability at 1 mM, respectively, compared to 78.49% cell viability for resveratrol as a standard positive control; (+)-catechin exerted the strongest neuroprotective activity through reversal of ROS generation, externalization of phosphatidylserine, mitochondrial membrane potential dissipation, and sub-G1 effects. These are in vitro findings only.

5.4 Immunomodulatory Activity

Evidence level: Preliminary — animal models only.

Research investigating the immunomodulatory potential of L. micranthus extracts epiphytic on Psidium guajava and Parkia biglobosa carried out phytochemical screening and acute toxicity testing to identify phytoconstituents and safety profiles; the extracts' innate and adaptive immunomodulatory potentials were determined in experimental animals using in vivo leucocyte mobilization, delayed-type hypersensitivity (DTH) response, hemagglutination antibody titre, and cyclophosphamide-induced myelosuppression models. The biological activities of the Nigerian Loranthus micranthus Linn., as summarized by Moghadamtousi and co-workers, include anti-diabetic, antimicrobial, immunomodulatory, antihypertensive, antioxidant, and antidiarrheal activities. No controlled human immunomodulation trials have been published.

5.5 Antimicrobial Activity

Evidence level: Preliminary — in vitro laboratory studies only.

Extracts from the fruits, leaves, and twigs of L. europaeus have been applied for their antimicrobial, anti-inflammatory, and wound-healing properties. Total phenolic content was determined as 34.49±1.78 and 55.82±2.34 mg/g for ethanol and methanol extracts respectively, and total flavonoid content as 46.10±2.40 and 55.49±1.15 mg/g; ethanol and methanol extracts were found to be effective against bacterial and fungal strains at concentrations between 50–200 µg/mL.

5.6 Anti-inflammatory Activity

Evidence level: Preliminary — animal models only.

Crude ethanolic extract and its fractions from L. acaciae were investigated for anti-inflammatory activity by the carrageenan-induced rat paw oedema method, while DPPH free radical scavenging and β-carotene bleaching assays were used to determine antioxidant activity. A potent anti-inflammatory effect (67.2% at 500 mg/kg) was detected for the chloroform fraction.

5.7 Antiallergic Activity

Evidence level: Preliminary — in vitro cell models only.

In one study, the water extract of Loranthus parasiticus (LPE) was evaluated for inhibition of IgE-mediated allergic responses in RBL-2H3 cells; LPE inhibited the release of β-hexosaminidase (IC50, 184.5 µg/mL) and the formation of tumor necrosis factor-α (IC50, 84.27 µg/mL), interleukin-4 (IC50, 93.43 µg/mL), prostaglandin E2 (IC50, 84.10 µg/mL), and leukotriene C4 (IC50, 43.27 µg/mL) in a concentration-dependent manner.

5.8 Anticancer / Antiproliferative Activity

Evidence level: Preliminary — in vitro and animal models only; no human clinical evidence.

Previous investigations on Loranthus plants have demonstrated antioxidant, anti-inflammatory, and analgesic activities; in addition, some Loranthus species indicated further important pharmacological effects including antimicrobial and potential antitumor activities. Anti-cancer studies involving L. micranthus have examined network pharmacology and in vitro targets. Network pharmacology analysis revealed 207 targets and 30 bioactive phytoconstituents of L. micranthus; these compounds, which include triterpenoids, alkaloids, steroids, and flavonoids, are known to have anti-inflammatory, antioxidant, antitumor, and immunomodulatory properties.

5.9 Anti-rheumatic / Anti-arthritic Activity

Evidence level: Preliminary — animal models only.

Traditional use of L. parasiticus in TCM for joint diseases and Wind-Damp conditions has received some pre-clinical investigation. In one animal study, oral administration of 100 mg/kg of lignans isolated from L. parasiticus was as effective as 0.3 mg/kg methotrexate (MTX) in reducing joint swelling, synovial hyperplasia, pannus formation, and levels of proinflammatory factors including serum IL-6 and IL-1β, and joint synovium IL-17. These results have not been replicated in human trials.

5.10 Anticholinesterase Activity

Evidence level: Preliminary — in vitro only.

The anti-AChE values of ethanol and methanol extracts of L. europaeus were determined as 13.51±0.81 and 22.79±1.86 µg/mL, respectively, and the anti-BChE values as 27.84±0.62 and 33.08±1.63 µg/mL; it was determined that L. europaeus has antioxidant, antimicrobial, and anticholinesterase activity, suggesting potential use as a natural material in pharmacological designs.

6. Body Systems Associated

• Metabolic / Endocrine System: Blood glucose regulation, lipid modulation, and insulin sensitivity, based on multiple animal studies across species.
• Cardiovascular System: Blood pressure reduction via vasorelaxation and nitric oxide pathways; lipid-lowering effects in animal models.
• Immune System: The leaves of L. micranthus have been proved to possess immunomodulatory, antidiabetic, antimicrobial, antihypertensive, antioxidant, antidiarrhoeal, and hypolipidemic activities.
• Nervous System: Neuroprotection against oxidative stress-induced cell death, in vitro.
• Hepatic System: Studies have identified antioxidative, antimutagenic, antiviral, antihepatotoxic, and antinephrotoxic activity for L. parasiticus.
• Renal System: Diuretic and nephroprotective activities reported for L. parasiticus in traditional use and some pre-clinical models.
• Musculoskeletal System: Traditional use for joint pain, back weakness, and arthritic conditions in TCM; supported by pre-clinical anti-rheumatic lignan research.
• Reproductive System: Traditional TCM use for threatened miscarriage and uterine bleeding during pregnancy, attributed to L. parasiticus.
• Integumentary System: Wound healing and antimicrobial applications associated with L. europaeus.

7. Dosages Reported in Studies

The following dosages are reported only as stated in identifiable source publications, and all are from pre-clinical (animal) models unless noted otherwise:

• L. micranthus methanolic leaf extract: 200 mg/kg, administered intraperitoneally to normoglycemic and alloxan-induced diabetic albino rats, compared to glibenclamide as positive control.
• L. micranthus weakly acidic fraction: 250 mg/kg and 400 mg/kg, administered intraperitoneally to alloxan-induced diabetic rats, alongside glibenclamide 10 mg/kg as positive control.
• L. micranthus fractions for antihypertensive/lipid studies: 250 mg/kg body weight of each fraction, administered orally to mice for 21 days.
• L. acaciae chloroform fraction and crude extract: 500 mg/kg, producing a significant hypoglycemic effect in diabetic rats with 47.0% and 33.6% reductions in blood sugar levels and 35.6% and 35.4% reductions in normoglycemic rats, respectively.
• L. parasiticus isolated lignans: 100 mg/kg orally for anti-rheumatic activity in an animal model.
• L. regularis extract: Administered orally to STZ-diabetic Wistar albino rats for 4 weeks in the hepatoprotective study. (Specific mg/kg dose not fully extracted from available abstract text.)

No standardized human clinical doses have been established in peer-reviewed literature. L. parasiticus usefulness as a medicinal plant with current widespread traditional use warrants further research, clinical trials, and product development to fully exploit its medicinal value.

8. Safety Considerations and Toxicology

General Safety Profile of L. parasiticus

L. parasiticus is one of the few Chinese herbal medicines included in healthy herbal drinks, indicating its low toxicity in humans. Moreover, L. parasiticus is one of the few Chinese medicinal herbs formulated into healthy herbal drinks in food processing pilot plants that did not reveal any mutagenicity effect against Salmonella typhimurium tester strains TA100 and TA98 when assessed by the Ames mutagenic test.

Safety of L. micranthus

The safety profile of L. micranthus has been reported: one study did not record any organ damage in the histological architecture of major organs after sub-acute toxicity studies in animals administered L. micranthus extract; another study did not identify any adverse biochemical changes or organ toxicity after mistletoe leaf meal-supplemented diets; based on acute toxicity test findings, the extracts were considered suitable for use as medicine.

Genotoxicity of L. europaeus Chloroform Extract

A notable toxicological finding has been reported specifically for the chloroform extract of L. europaeus. The genetic toxicity of Loranthus europaeus was investigated: chloroform extract of L. europaeus was used for investigation of genotoxic effects of different doses, administered orally, on bone marrow and peripheral blood cells of mice. Results showed that treatment with a large dose of the extract decreases the mitotic index and increases chromosomal aberration compared to vehicle-treated animals; the high dose also significantly decreased the total and differential white blood cell count compared to both the lower dose and methotrexate. In conclusion, the chloroform extract of L. europaeus shows pronounced gene toxicity with increasing dose when administered orally to mice. This effect was dose-dependent and specific to a particular extract fraction; it does not necessarily apply to other solvent fractions or other species.

Toxicology of Isolated Compounds from L. globosus

The sub-acute toxicities of two compounds — 3,4-dimethoxycinnamyl alcohol and 3,4,5-trimethoxycinnamyl alcohol — isolated from Loranthus globosus Roxb were studied on Long Evans rats, and the studies included gross general observation, changes in body weight, and haematological profiles.

Host-Dependent Phytochemical Variability as a Safety Consideration

Composition and hence biological activities of mistletoe are dependent on harvesting period and host tree species. This variability has direct implications for both therapeutic consistency and toxicological predictability, as the same plant material harvested from different hosts or at different times may differ substantially in its chemical profile and biological potency.

Traditional Safety Characterization

In traditional Chinese medicine practice, Sang Ji Sheng is generally characterized as very safe and as one of the few Wind-Damp herbs considered safe to use throughout pregnancy. However, this characterization reflects traditional empirical observation, not controlled clinical safety studies.

Overall Evidence Gap

Across the genus, human safety data remain minimal. The majority of safety data come from in vitro studies, sub-acute animal toxicity experiments, and traditional practice records. No large-scale, systematic human safety trials have been conducted for any Loranthus species as a dietary supplement. Pharmacological studies have demonstrated significant biological activities supporting traditional use of L. parasiticus as a neuroprotective, tranquilizing, anticancer, immunomodulatory, antiviral, diuretic, and hypotensive agent, but clinical validation is lacking across all these applications.

References

• Moghadamtousi SZ et al. "Phytochemistry and biology of Loranthus parasiticus Merr, a commonly used herbal medicine." The American Journal of Chinese Medicine, 2014. PubMed PMID 24467533
• Moghadamtousi SZ et al. "Phytochemistry and Biology of Loranthus parasiticus Merr, a Commonly Used Herbal Medicine." Am J Chin Med. 2014;42(1):23–35. World Scientific
• Zorofchian Moghadamtousi S et al. "Loranthus micranthus Linn.: Biological Activities and Phytochemistry." Evidence-Based Complementary and Alternative Medicine, 2013. PMC3784240
• Loranthus micranthus Linn.: Biological Activities and Phytochemistry. PubMed PMID 24109490
• Noman OM et al. "Phytochemical analysis and anti-diabetic, anti-inflammatory and antioxidant activities of Loranthus acaciae Zucc. grown in Saudi Arabia." PMC6598209
• Al-Taweel AM et al. "Protective Role of Loranthus regularis against Liver Dysfunction, Inflammation, and Oxidative Stress in Streptozotocin Diabetic Rat Model." PMC7787746
• Iyare EE et al. "Evaluation of the Possible Mechanisms of Antihypertensive Activity of Loranthus micranthus: An African Mistletoe." PMC3171764
• Evaluation of the Possible Mechanisms of Antihypertensive Activity of Loranthus micranthus. PubMed PMID 21918720
• Osadebe PO et al. "Study on anti-diabetic activities of crude methanolic extracts of Loranthus micranthus sourced from five different host trees." PubMed PMID 15507325
• Antidiabetic principles of Loranthus micranthus Linn. parasitic on Persea americana. ScienceDirect
• Bactericidal Activity of Protein Extracts from Loranthus europaeus Berries. PMC7168301
• Biological activities and phytochemical composition of organs from Loranthus europaeus. ScienceDirect
• Inhibitory Effect of Loranthus parasiticus on IgE-Mediated Allergic Responses in RBL-2H3 Cells. PMC5059555
• Phytochemical Profiling, and Antioxidant Potentials of South African and Nigerian Loranthus micranthus Linn. PMC10222921
• Immunomodulatory effects of epiphytic Loranthus micranthus leaf extracts. PMC10759741
• Comprehensive analysis of protective effects of Loranthus tanakae on atopic dermatitis. PMC12082742
• Toxicological studies of two compounds isolated from Loranthus globosus Roxb. PubMed PMID 19093449
• Vidal-Russell R, Nickrent DL. "Evolutionary relationships in the showy mistletoe family (Loranthaceae)." American Journal of Botany, 2008
• Anti-cancer effect of Loranthus micranthus via downregulation of inflammation, tryptophan catabolism and kynurenine synthesis. ScienceDirect
• Loranthus. Wikipedia (taxonomy and species list)
• Loranthaceae. Encyclopaedia Britannica
• Antiproliferative, antioxidant and phytochemical analysis of Loranthus europaeus fruits. ResearchGate / Vietnam Journal of Chemistry, 2024
• Hematopoietic toxicity of Loranthus europaeus chloroform extract: In vivo study. ResearchGate
• Loranthus europaeus Jacq. in European broadleaf forests: Ecology, impact, and management implications. ScienceDirect, 2026